title: Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.
authors.affiliation: Cytel Corporation, San Diego, California 92121, USA.
authors.forename: R W
authors.initials: RW
authors.lastname: Chesnut
authors.forename: A
authors.initials: A
authors.lastname: Sette
authors.forename: E
authors.initials: E
authors.lastname: Celis
authors.forename: P
authors.initials: P
authors.lastname: Wentworth
authors.forename: R T
authors.initials: RT
authors.lastname: Kubo
authors.forename: J
authors.initials: J
authors.lastname: Alexander
authors.forename: G
authors.initials: G
authors.lastname: Ishioka
authors.forename: A
authors.initials: A
authors.lastname: Vitiello
authors.forename: H M
authors.initials: HM
authors.lastname: Grey
mesh_terms: D000818:Animals; D015195:Drug Design; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D007167:Immunotherapy; D007239:Infections / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy*; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D010455:Peptides